Add to ORKGEditorial for the special issue: "From extended spectrum beta-lactamases to carbapenemases: the never ending challenge against Gram-negative bacteria
Antimicrobial drug resistance seen among many gram-negative bacteria, especially those expressing th...
AbstractAntibiotic resistance is a problem of deep scientific concern both in hospital and community...
ABSTRACTThe emergence of resistance in Gram-negative pathogens has alarmed many clinicians and healt...
Editorial for the special issue: "From extended spectrum beta-lactamases to carbapenemases: the neve...
In bacteria, a major resistance mechanism to β-lactam antibiotics is the production of one or more β...
Infectious diseases due to Gram-negative bacteria are a leading cause of morbidity and mortality wor...
Infectious diseases due to Gram-negative bacteria are a leading cause of morbidity and mortality wor...
The first b-lactamase was identified in an isolate of Escherichia coli in 1940. To date, there are 1...
Extended-spectrum b-lactamases (ESBLs) produced by Klebsiella pneumoniae, Escherichia coli, Proteus ...
Antimicrobial resistance due to the continuous selective pressure from widespread use of antimicrobi...
Several antimicrobial agents are being investigated as alternatives to carbapenems in the treatment ...
Extended-spectrum ß-lactamases (ESBLs) are a rapidly evolving group of ß-lactamases which share the ...
Antimicrobial drug resistance seen among many gram-negative bacteria, especially those expressing th...
Global trade and mobility of people has increased rapidly over the last 20 years. This has had profo...
International audienceDuring the last decade, community-acquired extended-spectrum beta-lactamase (E...
Antimicrobial drug resistance seen among many gram-negative bacteria, especially those expressing th...
AbstractAntibiotic resistance is a problem of deep scientific concern both in hospital and community...
ABSTRACTThe emergence of resistance in Gram-negative pathogens has alarmed many clinicians and healt...
Editorial for the special issue: "From extended spectrum beta-lactamases to carbapenemases: the neve...
In bacteria, a major resistance mechanism to β-lactam antibiotics is the production of one or more β...
Infectious diseases due to Gram-negative bacteria are a leading cause of morbidity and mortality wor...
Infectious diseases due to Gram-negative bacteria are a leading cause of morbidity and mortality wor...
The first b-lactamase was identified in an isolate of Escherichia coli in 1940. To date, there are 1...
Extended-spectrum b-lactamases (ESBLs) produced by Klebsiella pneumoniae, Escherichia coli, Proteus ...
Antimicrobial resistance due to the continuous selective pressure from widespread use of antimicrobi...
Several antimicrobial agents are being investigated as alternatives to carbapenems in the treatment ...
Extended-spectrum ß-lactamases (ESBLs) are a rapidly evolving group of ß-lactamases which share the ...
Antimicrobial drug resistance seen among many gram-negative bacteria, especially those expressing th...
Global trade and mobility of people has increased rapidly over the last 20 years. This has had profo...
International audienceDuring the last decade, community-acquired extended-spectrum beta-lactamase (E...
Antimicrobial drug resistance seen among many gram-negative bacteria, especially those expressing th...
AbstractAntibiotic resistance is a problem of deep scientific concern both in hospital and community...
ABSTRACTThe emergence of resistance in Gram-negative pathogens has alarmed many clinicians and healt...